Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 22Dermatologic 14Head & Neck 9Gastrointestinal 7Sarcoma 5Genitourinary 5CNS 5Lymphoid 4Endocrine 3Breast 3Tumor-Agnostic 2Plasma cell 2Other solid neoplasm 2Gynecologic 2Other hematologic neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Pathologic Complete Response 1Neoplasms 1Hemangiosarcoma 1

Interventions

Fulvestrant 81Letrozole 74Paclitaxel 73pembrolizumab 68Specimen Handling 63Trastuzumab 62Carboplatin 55Magnetic Resonance Spectroscopy 50ribociclib 48Capecitabine 48Anastrozole 45palbociclib 44pertuzumab 43Cyclophosphamide 39Tamoxifen 38exemestane 37abemaciclib 37Biopsy 36trastuzumab deruxtecan 31Docetaxel 28Taxes 27Radiotherapy 26Gemcitabine 25Surveys and Questionnaires 24Standard of Care 23130-nm albumin-bound paclitaxel 23Blood Specimen Collection 22olaparib 21sacituzumab govitecan 20eribulin 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
cemiplimab × Breast × 90 days × Clear all
NCT06860815 2026-05-20

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

City of Hope Medical Center

Phase 2 Recruiting
11 enrolled
Breast

Breast Neoplasms

NCT01042379 2026-05-06

I-SPY

QuantumLeap Healthcare Collaborative

Phase 2 Recruiting
5,000 enrolled
BreastSarcoma

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT05064085 2026-04-06

Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
13 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡